Science

Chris Collins’ Indictment Reveals Dark Side of Immunotherapy

INSIDER TRADING

MIS416 was touted as a miracle drug that could potentially cure a severe form of multiple sclerosis. But it might have been hyped up too quickly.

Tanya Basu
Tanya Basu 

Senior Editor, Science

chris collins rep new york ny immunotherapy mis416 secondary progressive multiple sclerosis spms innate australia insider trading fraud
Tom Williams/Getty
Tanya Basu

Tanya Basu

Senior Editor, Science

tanyabasu

Got a tip? Send it to The Daily Beast here.

Trending Now
OpinionIcarus 2.0: Did Kimberly Guilfoyle Fly Too Close to the Son?
Nell Scovell
PoliticsTrump Picks Fight With Pope With New Vatican Ambassador
Amethyst Martinez
Biden WorldPete Buttigieg Pokes Very Convincing Hole in New Jersey Drone Scare
David Gardner
BeautyThis Clinically-Backed K-Beauty Night Cream Is the Ultimate Winter Skin Antidote
Mia Maguire
exclusivePrince Andrew Set to Flee England for Controversial Secret Palace Overseas
Tom Sykes